As GRP75 levels are decreased in multiple cell types of FRDA patients [102], restoring GRP75 might be effective in treating both typical FRDA patients with two GAA repeat expansions and compound heterozygous patients with point mutations. Here, HSPA9 is linked to Friedreich ataxia.